Tropane alkaloid multidrug resistance inhibitors from...

Details Tropane alkaloid multidrug resistance inhibitors from... Tropane alkaloid multidrug resistance inhibitors from...

2006-01-24

2006-01-24

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S124000, C514S350000

Reexamination Certificate

active

06989396

ABSTRACT:
Compounds and methods of modulating the activity of P-glycoproteins are disclosed. The method utilizes compounds derived fromErythroxylum pervillei.The compounds overcome multidrug resistance and can be used therapeutically to enhance performance of therapeutic drugs, like chemotherapeutic drugs and antibiotics.

REFERENCES:
patent: 0 787 716 (1997-08-01), None
patent: WO 97/01336 (1997-01-01), None
Glaser, Robert et al. “Stereochemistry of the N-methyl Group in Salts of Tropane Alkaloids,” J. Org. Chem. (1998), vol. 53, pp 2172-2180.
Chavez et al.,J. Nat. Prod., 65, 606-610, (2002).
Silva et al.,J. Nat. Prod, 64, 1514-1520, (2001).
Mi et al.,Cancer Research, 61, 4030-4037, (2001).
M.M. Gottesman et al.,Ann. Rev. Biochem., 62: 385-427, (1993).
M. Horio et al.,Biochem. Biophys. Acta, 1061:106-110, (1991).
W.V.D. Vrie et al.,Crit. Rev. Clin. Lab. Sci., 35:1-57, (1998).
A.H. Dantzig et al.,Cancer Res., 56:4171-4179, (1996).
J.M. Ford et al.,Pharmacol. Rev., 42: 155-199, (1990).
T. Watanabe et al.,Acta Oncol., 34:235-241, (1995).
H.L. Pearce et al.,Proc. Natl. Acad. Sci. USA, 86:5128-5132, (1989).
H. Echizen et al.,Am. Heart J., 109:210-217, (1985).
M. Naito et al.,Cancer Chemother. Pharmacol., 40:S20-S24, (1997).
F. Bichat et al.,Biochem. Pharmacol., 56:497-502, (1998).
F. Hyafil et al.,Cancer Res., 53: 4595-4602, (1993).
T. Tsuruo et al.,Cancer Res., 43: 2905-2910, (1983).
T. Tsuruo et al.,Cancer Treat. Rep., 69:523-525, (1985).
H. Shinoda et al.,Cancer Res., 49:1722-1726, (1989).
A. Kiue et al.,Br. J. Cancer.; 64:221-226, (1991).
L. Kraus-Berthier et al.,Acta Oncol., 33:631-637, (1994).
W.T. Bellamy et al.,Cancer Invest., 8:547-562, (1990).
G.D. Pennock et al.,J. Natl. Cancer Inst., 83:105-110, (1991).
K. Ueda et al.,Anti-Cancer Drug Des., 14:115-121 (1999).
M.J. Newman et al.,Cancer Res., 2964-72, (2000).
M. You et al.,J. Nat. Prod., 57:1517-1522, (1994).
M. You et al.,J. Nat. Prod., 58:598-604, (1995).
G.L. Silva et al.,J. Nat. Prod., 64, pp. 1514-1520 (2001).
J.J. Casciari et al.,J. Natl. Cancer Inst., 86:1846-1852, (1994).
M.G. Hollingshead et al.,Life Sci., 57:131-141, (1995).
W.T. Beck et al.,Cancer Res., 39:2070-2079, (1979).
W.T. Beck et al.,Cancer Res., 46:778-784, (1986).
M.M. Cornwell et al.,J. Biol Chem., 281: 7921-7928, (1986).
A. Somanabandhu et al.,J. Nat. Prod., 56:233-239, (1993).
L.L. Song et al.,Cancer Res., 59:578-585, (1999).
A. Fojo et al.,Cancer Res., 45:3002-7, (1985).
L. Wu et al.,Cancer Res., 52:3029-3034, (1992).
V. Gekeler et al.,Biochem. Biophys. Res. Commun., 206:119-126, (1995).
D.P. Waller et al.,Contraception, 22:183-187, (1980).
D. Shen et al.,J. Biol. Chem., 261:7762-7770, (1986).
K.N. Thimmaraih et al.,Oncol. Res., 10: 29-41, (1998).
C. Muller et al.,Int. J. Cancer, 56: 749-754, (1994).
K.E. Sampson et al.,Cancer Lett., 68:7-14, (1993).
Y.P. Hu et al.,Anti-Cancer Drugs, 7:738-744, (1996).
M.M. Cornwell et al.,J. Biol. Chem., 262:2166-2170, (1987).
C. Pascuad et al.,Biochem. J., 333:351-358, (1998).
W.D. Stein,Physiol. Rev. 77:545-590, (1997).
G. Klopman et al.,Mol. Pharmacol., 52:323-334, (1997).
J.M. Zamora et al.,Mol. Pharmacol., 33:454-462, (1988).
J.L. Weaver et al.,Int. J. Cancer, 54:456-461, (1993).
G. Klopman et al.,Cancer Res., 52:4121-4129, (1992).
R.M. Phillipes et al.,Cancer Res., 58:5263-5266, (1998).
M.S. Al-Said et al.,Phytochemistry, 25, 851-853, (1986).
C.G. Chaves et al., C.G.; Schapoval, E.E.S.; Zuanazzi, J.A.; Diehl, E.; de Siqueira, N.C.S.; Henriques, A.T.,Erythoxylum argentinum: Assays for Anti-inflammatory Activity.,J. Ethnopharmacol., 22, 117-120, (1988).
K. Doerk-Schmitz et al.,Phytochemistry, 35, 107-110 (1994).
G. Fodor et al.,Nat. Prod. Rep., 11, 443-450, (1994).
R. Glaser et al.,J. Org. Chem., 53, 2172-2180 (1988).
M.S. Al-Said et al.,J. Chem. Soc., Perkin Trans., 1: 957-959, (1986).
J.T. Agar et al.,J. Chem. Soc., Perkin Trans., 1: 1550-1553, (1976).
A.L. Payo-Hill et al.,Phytochemistry, 54, 927-932, (2000).
T.A. Broadbent et al.,Heterocycles, 20, 863-980, (1983).
G.A. Cordell et al.,Tetrahedron, 47, 3521-3534, (1991).
E. Wenkert et al.,Acc. Chem. Res., 7, 46-51, (1974).
C.S. Huber et al.,Can. J. Chem., 49, 3258-3271, (1971).
K. Likhitwitayawuid et al.,J. Nat. Prod., 56, 30-38, (1993).
H.H Lee et al.,Anti-cancer Drug Design, 14, 487-497, (1999).
F. Hyafil et al.,Cancer Res., 534595-4602, (1993).
M.E. Wall et al.,J. Med. Chem., 37, 1465-1470, (1994).
F.J. Sharom et al.,Biochem. Pharmacol., 58, 571-586, (1999).
M.N. Prichard et al.,Antiviral Res., 14, 181-206, (1990).
Q. Mi et al.,Cancer Res., 61, pp. 4030-4037, (2001).

Affiliated with

Also associated with

Rating

Tropane alkaloid multidrug resistance inhibitors from... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tropane alkaloid multidrug resistance inhibitors from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tropane alkaloid multidrug resistance inhibitors from... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3538277